Matches in Wikidata for { <http://www.wikidata.org/entity/Q91421050> ?p ?o ?g. }
Showing items 1 to 75 of
75
with 100 items per page.
- Q91421050 description "articolo scientifico (pubblicato il 2019)" @default.
- Q91421050 description "artikull shkencor i botuar më 01 shkurt 2019" @default.
- Q91421050 description "artículu científicu espublizáu en febreru de 2019" @default.
- Q91421050 description "im Februar 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q91421050 description "scientific article published on 01 February 2019" @default.
- Q91421050 description "wetenschappelijk artikel" @default.
- Q91421050 description "наукова стаття, опублікована 1 лютого 2019" @default.
- Q91421050 name "A Highly Selective Rho-Kinase Inhibitor (ITRI-E-212) Potentially Treats Glaucoma Upon Topical Administration With Low Incidence of Ocular Hyperemia" @default.
- Q91421050 name "A Highly Selective Rho-Kinase Inhibitor (ITRI-E-212) Potentially Treats Glaucoma Upon Topical Administration With Low Incidence of Ocular Hyperemia" @default.
- Q91421050 name "A Highly Selective Rho-Kinase Inhibitor (ITRI-E-212) Potentially Treats Glaucoma Upon Topical Administration With Low Incidence of Ocular Hyperemia" @default.
- Q91421050 type Item @default.
- Q91421050 label "A Highly Selective Rho-Kinase Inhibitor (ITRI-E-212) Potentially Treats Glaucoma Upon Topical Administration With Low Incidence of Ocular Hyperemia" @default.
- Q91421050 label "A Highly Selective Rho-Kinase Inhibitor (ITRI-E-212) Potentially Treats Glaucoma Upon Topical Administration With Low Incidence of Ocular Hyperemia" @default.
- Q91421050 label "A Highly Selective Rho-Kinase Inhibitor (ITRI-E-212) Potentially Treats Glaucoma Upon Topical Administration With Low Incidence of Ocular Hyperemia" @default.
- Q91421050 prefLabel "A Highly Selective Rho-Kinase Inhibitor (ITRI-E-212) Potentially Treats Glaucoma Upon Topical Administration With Low Incidence of Ocular Hyperemia" @default.
- Q91421050 prefLabel "A Highly Selective Rho-Kinase Inhibitor (ITRI-E-212) Potentially Treats Glaucoma Upon Topical Administration With Low Incidence of Ocular Hyperemia" @default.
- Q91421050 prefLabel "A Highly Selective Rho-Kinase Inhibitor (ITRI-E-212) Potentially Treats Glaucoma Upon Topical Administration With Low Incidence of Ocular Hyperemia" @default.
- Q91421050 P1433 Q91421050-4F2F35E5-DE30-4DE3-854D-6FA2133CE3EE @default.
- Q91421050 P1476 Q91421050-80C867DB-AD5C-4A1F-BACD-59B0EB0A0955 @default.
- Q91421050 P2093 Q91421050-0602A0A3-9641-4A7C-993F-0947D95C0B7E @default.
- Q91421050 P2093 Q91421050-1E6DC0CD-AC3D-4786-8CB6-3E7C50A61963 @default.
- Q91421050 P2093 Q91421050-2432C5AB-6740-4911-9471-6AE66B712AED @default.
- Q91421050 P2093 Q91421050-2A1068FA-2145-4318-B2FB-B9A1B11C98C7 @default.
- Q91421050 P2093 Q91421050-2C285E94-F7BC-4BC8-ADC2-AD7A57BD7735 @default.
- Q91421050 P2093 Q91421050-498187AD-2B2E-433D-8889-F7FE99A55906 @default.
- Q91421050 P2093 Q91421050-5D1C8BD5-EE8C-4947-84F3-6D736C2D0F64 @default.
- Q91421050 P2093 Q91421050-5EA2BDC2-AFF8-4E21-A7C1-D433CC078D3A @default.
- Q91421050 P2093 Q91421050-6225F147-C92A-41BC-AE9D-2A6A8CDE15C9 @default.
- Q91421050 P2093 Q91421050-7C8FBAAF-8AC8-450F-9A3C-849FF9F675A0 @default.
- Q91421050 P2093 Q91421050-BF0C77FC-FB68-4A14-89B7-7D56EC92CD31 @default.
- Q91421050 P2093 Q91421050-C73BE7DA-0570-4D50-AB64-10473CAF54BB @default.
- Q91421050 P2093 Q91421050-DDD08A2A-92C7-478B-BD48-342D56B8D23A @default.
- Q91421050 P2093 Q91421050-DE3B7446-578F-4637-A36D-B4342119F211 @default.
- Q91421050 P2093 Q91421050-EA7249F4-863B-457F-AEC2-841B003DB5A3 @default.
- Q91421050 P2093 Q91421050-F17A4D73-AD18-4D45-A729-69194D667333 @default.
- Q91421050 P275 Q91421050-aaa37436-9a5b-4580-9cef-690e5bd049bb @default.
- Q91421050 P304 Q91421050-8CC1E313-E10B-45AE-8D44-891346B2C890 @default.
- Q91421050 P31 Q91421050-B48E4355-C132-4692-A7FF-07775EED3641 @default.
- Q91421050 P356 Q91421050-352CC5BF-74D0-431E-959D-1359BEE60A44 @default.
- Q91421050 P433 Q91421050-CC29CFD5-563D-4CF0-8582-6C5F7DD1BFBC @default.
- Q91421050 P478 Q91421050-6827B9C2-945F-4F37-BD9C-ED99B7C7450D @default.
- Q91421050 P577 Q91421050-1942AAED-DA5C-4921-9978-790608B38A12 @default.
- Q91421050 P6216 Q91421050-d11855e8-888f-4182-beb0-4a54a020ea95 @default.
- Q91421050 P698 Q91421050-5A456C5E-C5A4-4864-A909-B161BE0ED8B6 @default.
- Q91421050 P921 Q91421050-65201F2D-2831-4772-A17F-ECA916194C8D @default.
- Q91421050 P356 IOVS.18-25252 @default.
- Q91421050 P698 30735565 @default.
- Q91421050 P1433 Q6060707 @default.
- Q91421050 P1476 "A Highly Selective Rho-Kinase Inhibitor (ITRI-E-212) Potentially Treats Glaucoma Upon Topical Administration With Low Incidence of Ocular Hyperemia" @default.
- Q91421050 P2093 "Cherng-Ru Hsu" @default.
- Q91421050 P2093 "Chia-Mu Tu" @default.
- Q91421050 P2093 "Chih-Hung Chen" @default.
- Q91421050 P2093 "Chih-Lung Lin" @default.
- Q91421050 P2093 "Chih-Peng Liu" @default.
- Q91421050 P2093 "Chrong-Shiong Hwang" @default.
- Q91421050 P2093 "Da-Wen Lu" @default.
- Q91421050 P2093 "Jui-Wen Huang" @default.
- Q91421050 P2093 "Kuo-Kuei Huang" @default.
- Q91421050 P2093 "Meng-Nan Lin" @default.
- Q91421050 P2093 "Shuen-Hsiang Chou" @default.
- Q91421050 P2093 "Tze-Chung Lee" @default.
- Q91421050 P2093 "Wan-Ru Chen" @default.
- Q91421050 P2093 "Yi-Hsun Chen" @default.
- Q91421050 P2093 "Yi-Ling Hsu" @default.
- Q91421050 P2093 "Yu Chuan Huang" @default.
- Q91421050 P275 Q24082749 @default.
- Q91421050 P304 "624-633" @default.
- Q91421050 P31 Q13442814 @default.
- Q91421050 P356 "10.1167/IOVS.18-25252" @default.
- Q91421050 P433 "2" @default.
- Q91421050 P478 "60" @default.
- Q91421050 P577 "2019-02-01T00:00:00Z" @default.
- Q91421050 P6216 Q50423863 @default.
- Q91421050 P698 "30735565" @default.
- Q91421050 P921 Q18554326 @default.